Literature DB >> 21404983

Transfusion of blood and blood products: indications and complications.

Sanjeev Sharma1, Poonam Sharma, Lisa N Tyler.   

Abstract

Red blood cell transfusions are used to treat hemorrhage and to improve oxygen delivery to tissues. Transfusion of red blood cells should be based on the patient's clinical condition. Indications for transfusion include symptomatic anemia (causing shortness of breath, dizziness, congestive heart failure, and decreased exercise tolerance), acute sickle cell crisis, and acute blood loss of more than 30 percent of blood volume. Fresh frozen plasma infusion can be used for reversal of anticoagulant effects. Platelet transfusion is indicated to prevent hemorrhage in patients with thrombocytopenia or platelet function defects. Cryoprecipitate is used in cases of hypofibrinogenemia, which most often occurs in the setting of massive hemorrhage or consumptive coagulopathy. Transfusion-related infections are less common than noninfectious complications. All noninfectious complications of transfusion are classified as noninfectious serious hazards of transfusion. Acute complications occur within minutes to 24 hours of the transfusion, whereas delayed complications may develop days, months, or even years later.

Entities:  

Mesh:

Year:  2011        PMID: 21404983

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  47 in total

Review 1.  Red blood cell transfusion policy: a critical literature review.

Authors:  Massimo Franchini; Giuseppe Marano; Carlo Mengoli; Simonetta Pupella; Stefania Vaglio; Manuel Muñoz; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2017-07       Impact factor: 3.443

2.  Does intraoperative cell salvage system effectively decrease the need for allogeneic transfusions in scoliotic patients undergoing posterior spinal fusion? A prospective randomized study.

Authors:  Jinqian Liang; Jianxiong Shen; Sooyong Chua; Yu Fan; Jiliang Zhai; Bin Feng; Siyi Cai; Zheng Li; Xuhong Xue
Journal:  Eur Spine J       Date:  2014-03-30       Impact factor: 3.134

3.  2017 Military Supplement: Hemoglobin-based Oxygen Carriers: Current State-of-the-Art and Novel Molecules.

Authors:  Anirban Sen Gupta
Journal:  Shock       Date:  2017-09-29       Impact factor: 3.454

4.  A cross-sectional study of prevalence, distribution, cause, and impact of blood product recalls in the United States.

Authors:  Ibrahim Alqemlas; Sneha Shankar; Winode Handagama; P Arthur Felse
Journal:  Blood Adv       Date:  2020-04-28

Review 5.  Bio-inspired nanomedicine strategies for artificial blood components.

Authors:  Anirban Sen Gupta
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2017-03-15

6.  The role of intraoperative cell salvage system on blood management in major orthopedic surgeries: a cost-benefit analysis.

Authors:  Altuğ Duramaz; Mustafa Gökhan Bilgili; Berhan Bayram; Nezih Ziroğlu; Erdem Edipoğlu; Halil Nadir Öneş; Cemal Kural; Mustafa Cevdet Avkan
Journal:  Eur J Orthop Surg Traumatol       Date:  2017-12-06

Review 7.  Red blood cell storage time and transfusion: current practice, concerns and future perspectives.

Authors:  María García-Roa; María Del Carmen Vicente-Ayuso; Alejandro M Bobes; Alexandra C Pedraza; Ataúlfo González-Fernández; María Paz Martín; Isabel Sáez; Jerard Seghatchian; Laura Gutiérrez
Journal:  Blood Transfus       Date:  2017-05       Impact factor: 3.443

8.  Ensemble learning approaches to predicting complications of blood transfusion.

Authors:  Dennis Murphree; Che Ngufor; Sudhindra Upadhyaya; Nagesh Madde; Leanne Clifford; Daryl J Kor; Jyotishman Pathak
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2015-08

9.  Incidence and pattern of 12 years of reported transfusion adverse events in Zimbabwe: a retrospective analysis.

Authors:  Nyashadzaishe Mafirakureva; Star Khoza; David A Mvere; McLeod E Chitiyo; Maarten J Postma; Marinus Van Hulst
Journal:  Blood Transfus       Date:  2014-01-02       Impact factor: 3.443

10.  Plant-produced human recombinant erythropoietic growth factors support erythroid differentiation in vitro.

Authors:  Konstantin Musiychuk; Rajarajeswari Sivalenka; Jennifer Jaje; Hong Bi; Rosemary Flores; Brenden Shaw; R Mark Jones; Tatiana Golovina; Jacob Schnipper; Luipa Khandker; Ruiqiang Sun; Chang Li; Lin Kang; Vanessa Voskinarian-Berse; Xiaokui Zhang; Stephen Streatfield; John Hambor; Stewart Abbot; Vidadi Yusibov
Journal:  Stem Cells Dev       Date:  2013-05-14       Impact factor: 3.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.